Author

Johanna Lehtonen

Oslo University Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Antti HassineniD· 1 shared Antti Sakari RannikkoiD· 1 shared Erika Romppanen· 1 shared Janna SaarelaiD· 1 shared Katja Välimäki· 1 shared Minna Malmstedt· 1 shared Minttu PolsoiD· 1 shared Olli KallioniemiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Antti HassinenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJun 25, 2026

Pathway-centric multi-omics and functional precision medicine reveal shared drug vulnerabilities in heterogeneous adult Wilms tumor

Minttu Polso, Romika Kumari, Tamara J. Luck…·Vilja M. Pietiäinen

This study identifies shared drug vulnerabilities in adult Wilms tumor through multi-omics and functional assays, showing pathway-level dependencies predict drug responses better than single-gene biomarkers.

DOI 10.64898/2026.06.23.734042

humanwhole-exome sequencing

𝕏 PostBluesky